18KHT01, a Potent Anti-Obesity Polyherbal Formulation
Prakash Raj Pandeya1,2, Ramakanta Lamichhane1, Gopal Lamichhane1
1Department of Oriental Pharmacy and Wonkwang-Oriental Medicines Research Institute, Wonkwang University, Iksan, South Korea.
A novel herbal formulation, 18KHT01, demonstrates significant synergistic anti-obesity effects. This safe and potent therapy effectively reduces body weight, improves lipid profiles, and alleviates insulin resistance in preclinical models.
Area of Science:
- Metabolic disorders
- Pharmacology
- Natural product research
Background:
- Obesity is a critical metabolic disorder with limited safe and effective treatments.
- There is an urgent need for novel therapeutic strategies to manage obesity.
Purpose of the Study:
- To develop and evaluate a novel, safe, and effective polyherbal formulation (18KHT01) for obesity management.
- To investigate the synergistic antioxidant, anti-adipogenic, and anti-obesity activities of 18KHT01.
Main Methods:
- A polyherbal formulation (18KHT01) was created using Quercus acutissima, Camellia sinensis, Geranium thunbergii, and Citrus limon.
- In vitro and in vivo studies were conducted to assess antioxidant, anti-adipogenic, and anti-obesity effects in diet-induced obese mice.
- Molecular analysis targeted key adipogenic factors (PPARγ, C/EBPα, etc.).
Main Results:
- 18KHT01 exhibited strong synergistic antioxidant and anti-adipogenic activities in vitro.
- The formulation significantly downregulated key adipogenic factors.
- In vivo, 18KHT01 reduced body weight, improved lipid profiles, alleviated insulin resistance, and decreased fat deposition in liver and adipose tissue.
- Synergy evaluation confirmed improved efficacy and reduced toxicity of ingredients.
Conclusions:
- The polyherbal formulation 18KHT01 is a safe and potent herbal therapy for obesity management.
- 18KHT01 demonstrates significant synergistic effects, offering a promising approach to combat obesity.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drugs for Treatment of Constipation-Predominant IBS
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...


